[HTML][HTML] Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective
A Gupta, S Kashte, M Gupta, HC Rodriguez… - Human cell, 2020 - Springer
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …
related morbidity and mortality. Recent clinical evidences suggest increased level of …
Mesenchymal stem cells and their derived exosomes to combat Covid–19
M Yousefi Dehbidi, N Goodarzi… - Reviews in Medical …, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is causing an ongoing
pandemic of coronavirus disease 2019 (Covid‐19). Effective therapies are required for the …
pandemic of coronavirus disease 2019 (Covid‐19). Effective therapies are required for the …
[HTML][HTML] Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases
A Tsuchiya, S Takeuchi, T Iwasawa, M Kumagai… - Inflammation and …, 2020 - Springer
The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
the causative agent of coronavirus disease 2019 (COVID-19) and the ensuing worldwide …
the causative agent of coronavirus disease 2019 (COVID-19) and the ensuing worldwide …
Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study
M Dauletova, H Hafsan, N Mahhengam, AO Zekiy… - Clinical …, 2021 - Elsevier
In the past year, an emerging disease called Coronavirus disease 2019 (COVID-19), caused
by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been discovered in …
by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been discovered in …
The potential use of mesenchymal stem cells and their derived exosomes as immunomodulatory agents for COVID‐19 patients
A novel severe acute respiratory syndrome coronavirus (SARS‐CoV‐2) causing lethal acute
respiratory disease emerged in December 2019. The World Health Organization named this …
respiratory disease emerged in December 2019. The World Health Organization named this …
[HTML][HTML] Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects
Abstract Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …
[HTML][HTML] Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients
S Al-Khawaga, EM Abdelalim - Stem cell research & therapy, 2020 - Springer
The COVID-19 pandemic has negatively impacted the global public health and the
international economy; therefore, there is an urgent need for an effective therapy to treat …
international economy; therefore, there is an urgent need for an effective therapy to treat …
[HTML][HTML] Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatmen
K Jayaramayya, I Mahalaxmi, MD Subramaniam… - BMB …, 2020 - ncbi.nlm.nih.gov
The world has witnessed unimaginable damage from the coronavirus disease-19 (COVID-
19) pandemic. Because the pandemic is growing rapidly, it is important to consider diverse …
19) pandemic. Because the pandemic is growing rapidly, it is important to consider diverse …
[HTML][HTML] Mesenchymal stem cell-derived exosomes exhibit promising potential for treating SARS-CoV-2-infected patients
The novel coronavirus severe acute respiratory syndrome-CoV-2 (SARS-CoV-2) is
responsible for COVID-19 infection. The COVID-19 pandemic represents one of the worst …
responsible for COVID-19 infection. The COVID-19 pandemic represents one of the worst …
Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the
coronaviridae that causes respiratory disorders. After infection, large amounts of …
coronaviridae that causes respiratory disorders. After infection, large amounts of …